All stock reports

NURECA evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-24T23:40:59.339375+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1469630000.0
net_income
20820000.0
operating_cash_flow
85740000.0
free_cash_flow
17450000.0
total_assets
1961570000.0
total_liabilities
153960000.0
total_equity
1807600000.0
cash
414190000.0
total_debt
22590000.0
revenue_growth
0.3401573941510656
earnings_growth
1.4609929078014185
net_margin
0.014166831107149419
roe
0.011518034963487498
debt_to_equity
0.012497233901305598
cash_conversion
4.118155619596542
free_cash_flow_margin
0.011873736926981621
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-72cff61e6151c882a8f57a962299d992c7fe7ff93f466a93cab15ec9bfc9d9bd
Policy
stock-decisions-v1
Evidence bundle hash
f5b03eaa00ed1014bdd5b61159523678abbad483068461c8125167fc463accd7
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 0a9088f2e21f0eda52031d5733527fe246187a432a87fe8622d4420e64857f8a
  • daily-price: 29ea61ed4a7df32d49a2999f0f8449a8c90f47a2d41f5aaadb67a728999c053b
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was 2.19%. The trailing 20-session price return was 3.89%. The trailing 60-session price return was 54.64%. The trailing 250-session price return was 51.16%. Average cached traded value over twenty sessions was INR 3,525,071.

Risks

The closing price was -4.57% below its highest close in the available trailing year. The cached financial metric net margin is 0.014166831107149419. The cached financial metric roe is 0.011518034963487498. The cached financial metric debt to equity is 0.012497233901305598. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.3401573941510656. The cached financial metric cash conversion is 4.118155619596542. The cached financial metric free cash flow margin is 0.011873736926981621.

Cached observations and evidence limits